You will be seeing a lot of news coverage coming out of this week's cardiology conference about a large study of the statin drug, Crestor, which supposedly found it cut cardiovascular deaths in a group of people with normal LDL better than a placebo.What most news coverage is leaving out is this: The group of people with "normal" cholesterol who took Crestor in this study weren't just any old
